TOLPLUS Trademark

Trademark Overview

On Friday, April 27, 2018, a trademark application was filed for TOLPLUS with the United States Patent and Trademark Office. The USPTO has given the TOLPLUS trademark a serial number of 87897125. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 28, 2025. This trademark is owned by Nemysis Limited. The TOLPLUS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, medicines containing endopeptidases; oral peptidases compositions for the treatment of gluten intolerance
tolplus

General Information

Serial Number87897125
Word MarkTOLPLUS
Filing DateFriday, April 27, 2018
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 28, 2025
Registration Number5748677
Registration DateTuesday, May 14, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 26, 2019

Trademark Statements

Goods and ServicesPharmaceuticals, namely, medicines containing endopeptidases; oral peptidases compositions for the treatment of gluten intolerance

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 28, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNemysis Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDublin D02HF60
IE
Party NameNemysis Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDublin D02HF60
IE
Party NameNemysis Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDublin D02HF60
IE

Trademark Events

Event DateEvent Description
Tuesday, May 1, 2018NEW APPLICATION ENTERED
Sunday, May 6, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 14, 2018ASSIGNED TO EXAMINER
Wednesday, August 15, 2018NON-FINAL ACTION WRITTEN
Wednesday, August 15, 2018NON-FINAL ACTION E-MAILED
Wednesday, August 15, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, September 2, 2018TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, September 13, 2018ASSIGNED TO LIE
Monday, September 17, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, October 24, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 24, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 24, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 25, 2018SUSPENSION LETTER WRITTEN
Thursday, October 25, 2018LETTER OF SUSPENSION E-MAILED
Thursday, October 25, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, January 15, 2019TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, January 16, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 16, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 16, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 6, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 26, 2019PUBLISHED FOR OPPOSITION
Tuesday, February 26, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 14, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, April 12, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, May 14, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, November 28, 2025CANCELLED SEC. 8 (6-YR)

Related Keywords

tolplus compositions treatment gluten intolerance peptidases oral namely medicines containing endopeptidases